Carman Alenson - Jun 21, 2021 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Principal Accounting Officer
Signature: /s/ William Cook as attorney-in-fact for Carman Alenson
Stock symbol: AGIO
Transactions as of: Jun 21, 2021
Transactions value $: -$17,948
Form type: 4
Date filed: 6/23/2021, 05:28 PM
Next filing: Oct 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$91.5K	+1.78K		$51.51	1.78K	Jun 21, 2021	Direct	F1
transaction	AGIO	Common stock	Sale	-$109K	-1.78K	-100%	$61.61	0	Jun 21, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Stock option (right to buy)	Options Exercise	$0	-1.78K	-33.33%	$0.00	3.56K	Jun 21, 2021	Common stock	1.78K	$51.51	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3	This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.